Stock aaj or kal

STOCK IN FOCUS: MAHINDRA M&M delivers 3,000 XEV 9e and BE 6 electric SUVs since March 20. Booking trends show 59% demand for XEV 9e and 41% for BE 6. A majority of customers are opting for top-end variants of the EVs. #Mahindra #ElectricVehicles #XEV9e #BE6 #EVs #StockInFocus #AutoIndustry #M&M https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS: JEEVAN SCIENTIFIC Jeevan Scientific Technology Limited successfully completes CDSCO inspections of its clinical and bioanalytical facilities in Hyderabad. The company has confirmed compliance, with BA/BE study center registrations to be granted soon. #JeevanScientific #CDSCO #ClinicalTrials #Bioanalytical #StockInFocus #Compliance #Pharma #StockNews https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS: ASIAN WAREHOUSING Asian Warehousing Limited wins a ₹7.4 crore order from the Food Corporation of India for warehousing services in Jaipur. The project involves a storage capacity of 9,240 metric tonnes at an approved rate of ₹7.40 per quintal per month. #AsianWarehousing #WarehouseServices #FoodCorporationOfIndia #StockInFocus #OrderBook #StorageCapacity #StockNews

TOMORROW INDIAN MARKET WILL BE CLOSED ON SHRI MAHAVIR JAYANTI IMPORTANT TO NOTE: TOMORROW U.S. INFLATION DATA TO BE OUT + TRADE DEAL & TRUMP'S COMMENTARY IN FOCUS = UNCERTAINTY #IndianMarket #ShriMahavirJayanti #USInflation #TradeDeal #Trump #StockMarket #MarketUpdate https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS: J.P. MORGAN J.P. Morgan cuts 2025 UK GDP growth forecast to 0.6% (Q4/Q4) from the prior 1.1%. #JPMorgan #UKGDP #EconomicForecast #StockNews #GrowthForecast #UKEconomy

PHARMA: Fitch expects modest margin expansion for global healthcare providers in 2025. #Pharma #Healthcare #Fitch #GlobalHealthcare #MarginExpansion #StockNews

Cabinet approves 1,878 cr for 6-lane Zirakpur Bypass

Cabinet Approves 1,332 Cr For Railway Line In Tamil Nadu

KRBL Q4 ; FIIS REDUCED STAKE TO 5.13 % FROM 5.34% IN Q3

STOCK IN FOCUS: CHAVDA INFRA Chavda Infra wins ₹72.75 crore construction order for Nirma Limited's Corporate House in Ahmedabad. Project duration: 24 months with RCC, masonry, plaster, and other works. Total order value for 2025: ₹291.73 crore. Unexecuted order book: ₹797.82 crore. #ChavdaInfra #Construction #StockInFocus #OrderBook #Nirma #Ahmedabad #CorporateHouse #Infrastructure #StockNews

Tata Consultancy Services (TCS) is set to announce its Q4 FY25 results, with CNBC TV18 estimating: - **Revenue:** Up 1.2% quarter-on-quarter (QoQ) - **Dollar Revenue:** Down 0.8% QoQ - **Constant Currency Revenue Growth:** Flat - **Operating Margins:** Expected at 24.8%, compared to 24.5% in the previous quarter Investors are particularly keen on management's commentary regarding the FY26 outlook. #TCS #Q4Results #RevenueGrowth #Margins #ITSector #InvestorFocus #FY26Outlook #CNBCTV18 https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS: MONARCH NETWORTH CAPITAL FIIs trimmed their stake in Monarch Networth Capital to 1.36% in Q4, down from 1.55% in Q3. #MonarchNetworth #FIIs #StockInFocus #QuarterlyUpdate #MarketNews #InvestSmart #DalalStreet #Q4Update #IndianMarkets https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS: ZIM Laboratories ZIM Labs partners with Globalpharma Co. to commercialize Oral Thin Film products in the GCC region Deal covers dossier licensing, product supply, and tech licensing of ZIM’s ThinOral® platform Globalpharma to register and market 10 pharma and nutraceutical products ZIM to initially supply bulk and support regulatory needs, with local manufacturing to follow Strategic move to boost global presence with innovative dosage forms #ZIMLabs #Globalpharma #ThinOral #PharmaNews #StrategicPartnership #HealthcareInnovation #StockMarketIndia https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

ANMOL INDIA ; FIIS REDUCED STAKE TO 0.01% FROM 0.04% IN Q3

STOCK IN FOCUS: Glenmark Pharma Glenmark Pharma’s US arm recall of 39 drugs classified as Class-II — not a major issue Most recalls linked to product expiry dates (March 2025), making the move routine and reversible USFDA action indicates procedural compliance rather than safety concern #GlenmarkPharma #USFDA #DrugRecall #PharmaUpdate #StockMarketIndia #Class2Recall #HealthcareStocks https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS: Kalyani Steels Kalyani Steels Q4 update: FIIs reduced stake to 2.17%, down from 2.66% in Q3 Indicates slight decline in foreign investor interest this quarter #KalyaniSteels #Q4Update #FIIs #StockMarketIndia #SteelStocks #InvestorUpdate

STOCK IN FOCUS: Shilpa Medicare Shilpa Medicare gets USFDA approval for Varenicline Tablets, 0.5 mg and 1 mg Product approved as generic to Chantix by PF Prism C.V. Varenicline aids in smoking cessation; US market size is approx. $203M #ShilpaMedicare #USFDAApproval #PharmaStocks #GenericDrugs #Chantix #SmokingCessation #StockMarketIndia https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS: Glenmark Pharma US FDA lists Class-II recall of 39 drugs from Glenmark’s US arm Recall was initiated in March; classification done on April 8 Class-II recall requires manufacturer to take corrective action #GlenmarkPharma #USFDA #DrugRecall #PharmaNews #StockMarketIndia #HealthcareStocks https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS: Karnataka Bank Karnataka Bank Q4 update: FIIs increase stake to 12.88%, up from 11.22% in Q3 Sign of growing investor confidence and potential upside #KarnatakaBank #Q4Update #FIIs #StockMarketIndia #BankingStocks #InvestSmart https://t.co/k4XcnbTP97 Follow our telegram channel for more updates

STOCK IN FOCUS (SUMITOMO CHEMICAL INDIA) In Q4 FY25, Sumitomo Chemical India reported a slight increase in Foreign Institutional Investors (FIIs) holdings: - **FIIs stake**: Rose to 3.63% from 3.59% in Q3. This indicates a modest uptick in foreign investment during the quarter. #SumitomoChemicalIndia #FIIs #ShareholdingPattern #InvestmentUpdate #StockInFocus https://t.co/k4XcnbTP97 Follow our telegram channel for more updates